Skip to main content
HR 2113 116th Congress House Health Business records Civil actions and liability Congressional oversight Corporate finance and management Government information and archives Health care costs and insurance Inflation and prices Manufacturing Medicare Prescription drugs

Prescription Drug STAR Act

Introduced: May 22, 2019 Introduced by: Neal, Richard E. Democratic · Massachusetts See on congress.gov
Sign in to write a letter Sign in to watch
This bill died when the 116th Congress ended
It never became law before the 116th Congress (2019–2020) adjourned, and bills don't carry over to the next Congress. It would have to be reintroduced. You can still save it for reference, but it won't receive updates.
 Everywhere this bill has been 9 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Dec 24, 2020
Placed on the Union Calendar, Calendar No. 571.
Dec 24, 2020
Committee on Energy and Commerce discharged.
Dec 24, 2020
Reported (Amended) by the Committee on Ways and Means. H. Rept. 116-688, Part I.
Apr 9, 2019
Referred to the Subcommittee on Health.
Apr 9, 2019
Ordered to be Reported by Voice Vote.
Apr 9, 2019
Committee Consideration and Mark-up Session Held.
Apr 8, 2019
Referred to the Committee on Ways and Means, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Apr 8, 2019
Referred to the Subcommittee on Health.
Apr 8, 2019
Introduced in House
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Plain-English summary Congressional Research Service

Prescription Drug Sunshine, Transparency, Accountability and Reporting Act or the Prescription Drug STAR Act

This bill establishes requirements for prescription drug manufacturers to provide certain information about pricing, discounts, and product samples of applicable drugs. Specifically, the bill requires the Department of Health and Human Services (HHS) to annually determine whether there are price increases of a certain threshold for outpatient prescription drugs covered under Medicare, excluding low-cost drugs.

Manufacturers must provide HHS with an explanation for drug prices that (1) cumulatively increase by at least 10% or $10,000 over one year; (2) cumulatively increase by at least 25% or $25,000 over three years; or (3) are at least $26,000 annually, per individual, if first covered by Medicare during the applicable year. The manufacturer must explain the role of the factors contributing to such prices and other relevant information, including manufacturing costs, marketing costs, and revenue.

Additionally, drug manufacturers must provide HHS with aggregate data related to product samples of drugs, devices, biologic products, and medical supplies given to hospitals, physicians, or other medical professionals during the previous calendar year, beginning in 2023.

The bill further requires HHS to make publicly available the information related to drug discounts, rebates, and price concessions that is provided annually to HHS by group health plans. Drug manufacturers also must report to HHS certain sales information for drugs available under Medicare for which the manufacturer does not have a rebate agreement in place.

The bill requires HHS to study and report on trends concerning inpatient hospital drug costs.

What's happening now December 24, 2020

Placed on the Union Calendar, Calendar No. 571.

 Related & companion bills 5
  • HR 2087 Related bill Drug Price Transparency Act
  • HR 2115 Related bill Public Disclosure of Drug Discounts and Real-Time Beneficiary Drug Cost Act
  • S 2051 Related bill Strengthening Average Sales Price Reporting Act of 2019
  • HR 2064 Related bill To amend title XI of the Social Security Act to require manufacturers of certain drugs, devices, biologicals, and medic…
  • HR 2069 Related bill SPIKE Act
 Bill text 2 versions

Source documents hosted by congress.gov.

 Committees of jurisdiction 4
 Cosponsors 9
All 9 Democratic 5 Republican 2
R
Amodei, Mark E.
Nevada · Nov 5, 2019
 D
Lofgren, Zoe
California · Jun 13, 2019
Lipinski, Daniel
· May 22, 2019
 D
Slotkin, Elissa
Michigan · May 15, 2019
 D
Underwood, Lauren
Illinois · May 7, 2019
 D
Raskin, Jamie
Maryland · Apr 29, 2019
 D
Houlahan, Chrissy
Pennsylvania · Apr 18, 2019
 R
Van Drew, Jefferson
New Jersey · Apr 15, 2019
BRADY, KEVIN
· Apr 8, 2019
Cite this page click to expand
APA
U.S. Congress. (2026). H.R. 2113: Prescription Drug STAR Act. 116th Congress. Open America. https://openamerica.io/bill/116-HR-2113/
MLA
"H.R. 2113: Prescription Drug STAR Act." 116th Congress, 2026, Open America, https://openamerica.io/bill/116-HR-2113/.
Bluebook (legal)
H.R. 2113, 116th Cong. (2026), https://openamerica.io/bill/116-HR-2113/.
Markdown link
[H.R. 2113: Prescription Drug STAR Act](https://openamerica.io/bill/116-HR-2113/)
Report a problem